Please Wait.....
Report
Drug Discovery Informatics Market By Application (Drug Discovery, Drug Development), By Function (Sequencing and Target Data Analysis, Library and Database Preparation, Docking, Molecular Modelling, Others), By End User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Other End Users): Global Opportunity Analysis and Industry Forecast, 2023-2032
Market Report I 2024-03-01 I 280 Pages I Allied Market Research
The global drug discovery informatics market size was valued at $2.9 million in 2022 and is projected to reach $7.9 million by 2032, registering a CAGR of 10.5% from 2023 to 2032.m
Drug discovery informatics involves the utilization of information technology to aid researchers in the process of drug discovery and development. The key factors that drive drug discovery informatics market growth are the rise in the prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, high blood pressure, and various other diseases, the rise in R&D activities for drug discovery, and the surge in demand for target drug therapy. For instance, according to the report published by IQVIA in June 2022, it has been estimated that oncology trial starts reached historically high levels in 2021, up 56% from 2016 and mostly focused on rare cancer indications, a record 30 oncology novel active substances were initially launched globally in 2021, and a total of 159 have been launched since 2012. Thus, the rise in the number of research activities increases the demand for performing clinical trials to launch the new molecule in the market drives growth of the market.
Furthermore, the rise in usage of AI in drug discovery as well as rapid shift toward patent expiration, biologics, unprecedented downsizing of internal discovery of big pharmaceuticals, and surge in incidences of antibiotic resistance as well as drug resistance boost the growth of the market. However, the high cost of outsourcing services and stringent government regulations are the major barriers to the growth of the market. Conversely, rising cases of cancer, genetic diseases, chronic diseases, large geriatric population, favorable regulatory environment, and availability of low-cost skilled manpower with high-quality data in developing countries are expected to provide the drug discovery informatics market opportunity for growth during the forecast period.
The drug discovery informatics market is segmented into application, function, end user, and region. Based on application, the market is segmented into drug discovery and drug development. Based on function, the market is segmented into sequencing and target data analysis, library, and database preparation, docking, molecular modelling and others. Based on end users, the market is segmented into biotechnology companies, pharmaceutical companies, contract research organizations and other end users. Region wise, the drug discovery informatics market is segmented into North America, Europe, Asia-Pacific, and LAMEA.
Major companies operating in this market include Certara, Boehringer Ingelheim International GmbH, Infosys Ltd., Charles River Laboratories, Collaborative Drug Discovery, Inc., Eurofins DiscoverX Products, Jubilant Biosys, Selvita, Novo Informatics Pvt. Ltd., ChemAxon Ltd., Albany Molecular Research Inc., Oracle, Accenture, Agilent Technologies, Inc., and Illumina, Inc.
Key players have adopted partnership and collaboration as their key strategy to improve the product portfolio of the drug discovery informatics market.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the drug discovery informatics market analysis from 2022 to 2032 to identify the prevailing drug discovery informatics market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the drug discovery informatics market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global drug discovery informatics market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Criss-cross segment analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
- SWOT Analysis
Key Market Segments
By Application
- Drug Discovery
- Drug Development
By Function
- Sequencing and Target Data Analysis
- Library and Database Preparation
- Docking
- Molecular Modelling
- Others
By End User
- Biotechnology Companies
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Oracle Corporation
- Accenture
- Thermo Fisher Scientific
- Certara, Inc.
- Albany Molecular Research, Inc.
- Jubilant Pharmova
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Drug Discovery
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Drug Development
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION
5.1. Overview
5.1.1. Market size and forecast
5.2. Sequencing and Target Data Analysis
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Library and Database Preparation
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Docking
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Molecular Modelling
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: DRUG DISCOVERY INFORMATICS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Biotechnology Companies
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Pharmaceutical Companies
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Contract Research Organizations
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Other End Users
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
CHAPTER 7: DRUG DISCOVERY INFORMATICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Application
7.2.3. Market size and forecast, by Function
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Application
7.2.5.1.2. Market size and forecast, by Function
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Application
7.2.5.2.2. Market size and forecast, by Function
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Application
7.2.5.3.2. Market size and forecast, by Function
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Application
7.3.3. Market size and forecast, by Function
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Application
7.3.5.1.2. Market size and forecast, by Function
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Application
7.3.5.2.2. Market size and forecast, by Function
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Application
7.3.5.3.2. Market size and forecast, by Function
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Application
7.3.5.4.2. Market size and forecast, by Function
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Application
7.3.5.5.2. Market size and forecast, by Function
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Application
7.3.5.6.2. Market size and forecast, by Function
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Application
7.4.3. Market size and forecast, by Function
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Application
7.4.5.1.2. Market size and forecast, by Function
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Application
7.4.5.2.2. Market size and forecast, by Function
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. Australia
7.4.5.3.1. Market size and forecast, by Application
7.4.5.3.2. Market size and forecast, by Function
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. India
7.4.5.4.1. Market size and forecast, by Application
7.4.5.4.2. Market size and forecast, by Function
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Application
7.4.5.5.2. Market size and forecast, by Function
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Application
7.4.5.6.2. Market size and forecast, by Function
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Application
7.5.3. Market size and forecast, by Function
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Application
7.5.5.1.2. Market size and forecast, by Function
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Application
7.5.5.2.2. Market size and forecast, by Function
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Application
7.5.5.3.2. Market size and forecast, by Function
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Application
7.5.5.4.2. Market size and forecast, by Function
7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Oracle Corporation
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Accenture
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Thermo Fisher Scientific
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Certara, Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Albany Molecular Research, Inc.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Jubilant Pharmova
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 02. DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY, BY REGION, 2022-2032 ($MILLION)
TABLE 03. DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 05. DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING AND TARGET DATA ANALYSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 06. DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY AND DATABASE PREPARATION, BY REGION, 2022-2032 ($MILLION)
TABLE 07. DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY REGION, 2022-2032 ($MILLION)
TABLE 08. DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING, BY REGION, 2022-2032 ($MILLION)
TABLE 09. DRUG DISCOVERY INFORMATICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 11. DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 12. DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 13. DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022-2032 ($MILLION)
TABLE 14. DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. DRUG DISCOVERY INFORMATICS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 20. U.S. DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 21. U.S. DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 22. U.S. DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. CANADA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 24. CANADA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 25. CANADA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. MEXICO DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 27. MEXICO DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 28. MEXICO DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 30. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 31. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 32. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 33. GERMANY DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 34. GERMANY DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 35. GERMANY DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. FRANCE DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 37. FRANCE DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 38. FRANCE DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. UK DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 40. UK DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 41. UK DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. ITALY DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 43. ITALY DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 44. ITALY DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. SPAIN DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 46. SPAIN DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 47. SPAIN DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 55. JAPAN DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 56. JAPAN DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 57. JAPAN DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. CHINA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 59. CHINA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 60. CHINA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. INDIA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 65. INDIA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 66. INDIA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 74. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 75. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 76. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 77. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 78. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 79. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 87. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
TABLE 88. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 89. ORACLE CORPORATION: KEY EXECUTIVES
TABLE 90. ORACLE CORPORATION: COMPANY SNAPSHOT
TABLE 91. ORACLE CORPORATION: PRODUCT SEGMENTS
TABLE 92. ORACLE CORPORATION: SERVICE SEGMENTS
TABLE 93. ORACLE CORPORATION: PRODUCT PORTFOLIO
TABLE 94. ORACLE CORPORATION: KEY STRATERGIES
TABLE 95. ACCENTURE: KEY EXECUTIVES
TABLE 96. ACCENTURE: COMPANY SNAPSHOT
TABLE 97. ACCENTURE: PRODUCT SEGMENTS
TABLE 98. ACCENTURE: SERVICE SEGMENTS
TABLE 99. ACCENTURE: PRODUCT PORTFOLIO
TABLE 100. ACCENTURE: KEY STRATERGIES
TABLE 101. THERMO FISHER SCIENTIFIC: KEY EXECUTIVES
TABLE 102. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 103. THERMO FISHER SCIENTIFIC: PRODUCT SEGMENTS
TABLE 104. THERMO FISHER SCIENTIFIC: SERVICE SEGMENTS
TABLE 105. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 106. THERMO FISHER SCIENTIFIC: KEY STRATERGIES
TABLE 107. CERTARA, INC.: KEY EXECUTIVES
TABLE 108. CERTARA, INC.: COMPANY SNAPSHOT
TABLE 109. CERTARA, INC.: PRODUCT SEGMENTS
TABLE 110. CERTARA, INC.: SERVICE SEGMENTS
TABLE 111. CERTARA, INC.: PRODUCT PORTFOLIO
TABLE 112. CERTARA, INC.: KEY STRATERGIES
TABLE 113. ALBANY MOLECULAR RESEARCH, INC.: KEY EXECUTIVES
TABLE 114. ALBANY MOLECULAR RESEARCH, INC.: COMPANY SNAPSHOT
TABLE 115. ALBANY MOLECULAR RESEARCH, INC.: PRODUCT SEGMENTS
TABLE 116. ALBANY MOLECULAR RESEARCH, INC.: SERVICE SEGMENTS
TABLE 117. ALBANY MOLECULAR RESEARCH, INC.: PRODUCT PORTFOLIO
TABLE 118. ALBANY MOLECULAR RESEARCH, INC.: KEY STRATERGIES
TABLE 119. JUBILANT PHARMOVA: KEY EXECUTIVES
TABLE 120. JUBILANT PHARMOVA: COMPANY SNAPSHOT
TABLE 121. JUBILANT PHARMOVA: PRODUCT SEGMENTS
TABLE 122. JUBILANT PHARMOVA: SERVICE SEGMENTS
TABLE 123. JUBILANT PHARMOVA: PRODUCT PORTFOLIO
TABLE 124. JUBILANT PHARMOVA: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. DRUG DISCOVERY INFORMATICS MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF DRUG DISCOVERY INFORMATICS MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN DRUG DISCOVERY INFORMATICS MARKET
FIGURE 04. TOP INVESTMENT POCKETS IN DRUG DISCOVERY INFORMATICS MARKET (2023-2032)
FIGURE 05. BARGAINING POWER OF SUPPLIERS
FIGURE 06. BARGAINING POWER OF BUYERS
FIGURE 07. THREAT OF SUBSTITUTION
FIGURE 08. THREAT OF SUBSTITUTION
FIGURE 09. COMPETITIVE RIVALRY
FIGURE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING AND TARGET DATA ANALYSIS, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY AND DATABASE PREPARATION, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. DRUG DISCOVERY INFORMATICS MARKET BY REGION, 2022 AND 2032(%)
FIGURE 26. U.S. DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 27. CANADA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 28. MEXICO DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 29. GERMANY DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 30. FRANCE DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 31. UK DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 32. ITALY DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 33. SPAIN DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 34. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 35. JAPAN DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 36. CHINA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 37. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 38. INDIA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 39. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 40. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 41. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 42. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 43. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 44. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
FIGURE 45. TOP WINNING STRATEGIES, BY YEAR (2023-2023)
FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT (2023-2023)
FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY (2023-2023)
FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 49. COMPETITIVE DASHBOARD
FIGURE 50. COMPETITIVE HEATMAP: DRUG DISCOVERY INFORMATICS MARKET
FIGURE 51. TOP PLAYER POSITIONING, 2022
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security